News search

    E.g., 05/04/2025
    E.g., 05/04/2025
    Marta Amorós Pérez, Virginia Zorita, Nuria Matesanz, Marian Zuriaga y José Javier Fuster.
    About the CNIC
    23 Dec 2020
    CNIC to coordinate a European project investigating how cancer therapies promote atherosclerosis and cardiovascular disease

    The project will investigate the role of clonal hematopoiesis—the formation of mutated hematopoietic stem-cell clones promoted by anti-cancer therapies—in the development of atherosclerosis and associated cardiovascular disease
    Research
    29 Sep 2020
    JACC: CNIC scientists design an algorithm for personalized cardiovascular risk estimation in healthy people

    The study, published in JACC, forms part of the PESA-CNIC-SANTANDER project, led by Dr Valentín Fuster
    Experimental design of the study and summary of the results obtained
    Research
    21 Apr 2020
    JACC: Spanish scientists identify a biomarker that detects atherosclerosis before the appearance of symptoms

    The study, published today in JACC, shows that activation of the complement system is one of the most characteristic molecular changes taking place in the early stages of the development of atherosclerotic plaques
    En la imagen se muestra con un asterisco la presencia de una placa de aterosclerosis avanzada en la carótida común detectada por la técnica de ecografía 3D que no llega a ocasionar una obstrucción significativa de la luz del vaso (es <50%). Se puede comprobar con precisión su extensión en las 3 dimensiones del espacio lo que nos permite detectar cambios en su volumen para determinar si existe un avance de la enfermedad.
    Research
    7 Apr 2020
    JACC: Atherosclerosis progresses rapidly in healthy people from the age of 40

    A CNIC study published in JACC demonstrates that atheroma plaques extend rapidly in the arteries of asymptomatic individuals aged between 40 and 50 years participating in the PESA-CNIC-Santander study.
    About the CNIC
    12 Dec 2019
    Jacob Fog Bentzon receives 2 M euros from the European Research Council for a ground-breaking research project on atherosclerosis

    Professor Jacob Fog Bentzon from Aarhus University and the CNIC  receives 2 M euros from the European Research Council for a ground-breaking research project on atherosclerosis – one of the most frequent causes of death in the world
    Dr. José María Mendiguren, Director de Servicios Médicos de Banco Santander, Leticia Fernández-Friera, cardióloga del CNIC y del Hospital Universitario HM Montepríncipe, y Dr. Valentín Fuster, Director del CNIC.
    Research
    26 Mar 2019
    JACC: Advanced imaging technology predicts cardiovascular risk from inflammation detected in arteries

    The results, published in JACC, demonstrate the potential of this technology to generate images of the inflammation associated with systemic atherosclerosis; this information will be useful for the study of early stages of this disease and will help to identify individuals who will benefit from early medical intervention
    Pilar Gonzalo, Rosa Nevado, Ricardo Villa-Bellosta, Magda R. Hamczyk, María J. Andrés-Manzano, and Vicente Andrés.
    Research
    12 Mar 2019
    EMBO Molecular Medicine: CNIC scientists discover a new therapeutic target for blocking early atherosclerosis in progeria

    This new results, published in EMBO Molecular Medicine, identify a possible therapeutic target for this genetic disease
    Research
    16 Jan 2019
    JACC: The duration and quality of sleep is of vital importance in cardiovascular health

    Poor quality sleep increases the risk of atherosclerosis according to the PESA CNIC- Santander Study published in the Journal of the American College of Cardiology (JACC)
    Photo
    Research
    8 Jan 2019
    Circulation: Expression of a molecule in blood cells predicts atherosclerosis risk

    The expression on lymphocytes of the molecule CD69 inversely predicts the development of subclinical (symptom-free) atherosclerosis independently of classical cardiovascular risk factors
    Dr. Andrés Hidalgo
    About the CNIC
    4 Jul 2018
    CNIC coordinates a project from the Leducq Foundation

     ‘Clonal hematopoiesis and atherosclerosis’ will receive a total funding of $6,000,000, of which $712,500 correspond to the CNIC